Contact
searchSearch
HMP Global
Login
Videos

Utilizing Pathways for Diagnosis, Treatment, and Survivorship in Cancer Care

10/15/2022

Tatjana Kolevska, MD, Kaiser Permanente, presents at the 2022 Oncology Clinical Pathways Congress the importance of connecting all specialties in pathways, meaning screening, diagnosis, treatment, and survivorship, for consistent and up to date care.

Nov-Dec 2024 Issue Cover

Current Issue

December 2024
Volume 10
Issue 6
Current Issue
Issue Archive

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Recent Stories

Rodriguez Headshot
Interview
Balancing Novel Therapies and Equitable Access in NSCLC Treatment Pathways
12/12/2024
In this interview, Estelamari Rodriguez, MD, MPH, discusses the challenges and advancements in non-small cell lung cancer (NSCLC) care, including strategies for managing uncommon EGFR mutations, the potential of antibody-drug conjugates,...
In this interview, Estelamari Rodriguez, MD, MPH, discusses the challenges and advancements in non-small cell lung cancer (NSCLC) care, including strategies for managing uncommon EGFR mutations, the potential of antibody-drug conjugates,...
In this interview, Estelamari...
12/12/2024
Journal of Clinical Pathways
Dizon Headshot
Interview
Integrating Psychosocial Support and Quality of Life into Endometrial Cancer Pathways
12/12/2024
In this interview, Don S. Dizon, MD, discusses the need to address research gaps, integrate quality-of-life and psychosocial considerations, and improve care pathways to optimize outcomes for endometrial cancer patients.
In this interview, Don S. Dizon, MD, discusses the need to address research gaps, integrate quality-of-life and psychosocial considerations, and improve care pathways to optimize outcomes for endometrial cancer patients.
In this interview, Don S. Dizon,...
12/12/2024
Journal of Clinical Pathways
John Burke, MD
Interview
Challenges in Initiating Venetoclax-Based Treatment for Patients With CLL
12/11/2024
John M. Burke, MD, Rocky Mountain Cancer Centers, provides an overview of his study that examined the barriers providers face in initiating venetoclax-based treatment for patients with chronic lymphocytic leukemia (CLL).
John M. Burke, MD, Rocky Mountain Cancer Centers, provides an overview of his study that examined the barriers providers face in initiating venetoclax-based treatment for patients with chronic lymphocytic leukemia (CLL).
John M. Burke, MD, Rocky...
12/11/2024
Journal of Clinical Pathways
News
Model Predicts Outcomes After BCMA CAR-T in Patients With RRMM
12/10/2024
Researchers have created a model that uses disease-, treatment-, and inflammation-related variables to predict outcomes after anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T therapy (CAR-T) in patients with...
Researchers have created a model that uses disease-, treatment-, and inflammation-related variables to predict outcomes after anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T therapy (CAR-T) in patients with...
Researchers have created a model...
12/10/2024
Journal of Clinical Pathways
News
Addressing Racial and Ethnic Disparities in Cancer Clinical Trial Access
12/06/2024
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements, racial and ethnic inequities continue to occur in cancer clinical trial participation, exacerbating disparities in access to investigational therapies. A recent study published in JNCI Cancer Spectrum explored...
Despite research advancements,...
12/06/2024
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use